Skip to main content
Clinical Trials/CTRI/2024/03/064289
CTRI/2024/03/064289Not yet recruitingPhase 4

Egg shell derived hydroxyapatite as bone graft substitute

Dr Vivekanand Kattimani0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1)Patients who require grafting after extraction of the tooth to fill the bone deficient area.
  • 2)Patients with vertical and horizontal bone loss.
  • 3)Patients who require healthy ridge for prosthesis.
  • 4)Willing to participate in study and
  • followup visits

Exclusion Criteria

  • 1) Pregnant patients
  • 2) Medically compromised patients
  • 3) Metabolic diseases affecting bone regeneration- Diabetics,Thyroid.
  • 4)Not willing for regular followup visits

Investigators

Sponsor
Dr Vivekanand Kattimani

Similar Trials

Bone material produced from egg shell is... | Clinical Trial